Journal article

Evaluation of Circulating Tumor Cells and Circulating Tumor DNA in Non-Small Cell Lung Cancer: Association with Clinical Endpoints in a Phase II Clinical Trial of Pertuzumab and Erlotinib

Elizabeth A Punnoose, Siminder Atwal, Weiqun Liu, Rajiv Raja, Bernard M Fine, Brett GM Hughes, Rodney J Hicks, Garret M Hampton, Lukas C Amler, Andrea Pirzkall, Mark R Lackner

Clinical Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2012

DOI: 10.1158/1078-0432.CCR-11-3148

Grants

Funding Acknowledgements

The study was sponsored by Genentech.

Citation metrics

258Web of Science
255Scopus

Keywords

Survival
Endpoint Determination
Receptor, Epidermal Growth Factor
Disease-Free Survival
Growth-Factor Receptor
Oncology
Mutations
Lung Neoplasms
Male
Erbb Receptors
Neoplastic Cells, Circulating
Quinazolines
Antineoplastic Combined Chemotherapy Protocols
Science & Technology
Female
Erlotinib Hydrochloride
Progression-Free
Antibodies, Monoclonal, Humanized
Genotype
Carcinoma, Non-Small-Cell Lung
Biomarkers, Tumor
Life Sciences & Biomedicine
Positron-Emission Tomography
Humans
Dna, Neoplasm
Tumor Markers, Biological
Dimerization Inhibitor
Peripheral-Blood
Metastatic Breast-Cancer
Mutation